The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

Launched by FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY · Jul 27, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging technique called 68Ga-NOTA-exendin-4 PET/CT to help detect insulinomas, which are small tumors that can cause low blood sugar levels. Sometimes, traditional imaging methods like CT or MRI cannot find these tumors, so researchers are looking to see if this new method can improve detection for patients who have hypoglycemia linked to high insulin levels in their blood.

To participate in this study, you need to be at least 6 years old and have been diagnosed with low blood sugar due to elevated insulin. You should also have had a CT or MRI scan within the past month and be able to provide written consent to join the trial. If you decide to participate, you will receive a small injection, and the doctors will take images to see if they can locate the insulinoma. This trial is currently recruiting participants, and it's important to note that certain conditions, like pregnancy or specific kidney issues, may prevent someone from joining.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1.age ≥6 years old 2.Patients with hypoglycaemia 3.Endogenous hyperinsulinemic hypoglycaemia 4.Enhanced CT or MRI within 1 month 5.Signed written consent
• Exclusion Criteria:
• • 1. Breast feeding 2.Pregnancy or the wish to become pregnant within 6 months 3.Renal function: serum creatinine during 41-73umol/L 4.Any medical condition may significantly interfere with study compliance; 5.Known allergy